# Hyman B. Muss

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hyman-b-muss/

## Facts

| Field | Value |
| --- | --- |
| Citations | 47,501 |
| Field | Breast Cancer Treatment Studies |
| h-index | 98 |
| i10-index | 399 |
| Last Known Institution | University of North Carolina at Chapel Hill |
| OpenAlex ID | https://openalex.org/A5007726590 |
| ORCID iD | https://orcid.org/0000-0003-2862-9970 |
| Works | 842 |

## Researcher papers

- [A Randomized Trial of Letrozole in Postmenopausal Women after Five Years of Tamoxifen Therapy for Early-Stage Breast Cancer](https://scholariq.org/papers/a-randomized-trial-of-letrozole-in-postmenopausal-women-after-five-years-of/)
- [Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Positive Primary Breast Cancer: First Report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741](https://scholariq.org/papers/randomized-trial-of-dose-dense-versus-conventionally-scheduled-and-sequential/)
- [Lumpectomy Plus Tamoxifen With or Without Irradiation in Women Age 70 Years or Older With Early Breast Cancer: Long-Term Follow-Up of CALGB 9343](https://scholariq.org/papers/lumpectomy-plus-tamoxifen-with-or-without-irradiation-in-women-age-70-years-or/)
- [Lumpectomy plus Tamoxifen with or without Irradiation in Women 70 Years of Age or Older with Early Breast Cancer](https://scholariq.org/papers/lumpectomy-plus-tamoxifen-with-or-without-irradiation-in-women-70-years-of-age/)
- [Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline](https://scholariq.org/papers/endocrine-therapy-for-hormone-receptor-positive-metastatic-breast-cancer/)
- [Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update](https://scholariq.org/papers/breast-cancer-follow-up-and-management-after-primary-treatment-american-society/)
- [Older adult participation in cancer clinical trials: A systematic review of barriers and interventions](https://scholariq.org/papers/older-adult-participation-in-cancer-clinical-trials-a-systematic-review-of/)
- [Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials](https://scholariq.org/papers/increasing-the-dose-intensity-of-chemotherapy-by-more-frequent-administration-or/)

## Researcher topics

- [Breast Cancer Treatment Studies](https://scholariq.org/topics/breast-cancer-treatment-studies/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Cancer survivorship and care](https://scholariq.org/topics/cancer-survivorship-and-care/)
- [Frailty in Older Adults](https://scholariq.org/topics/frailty-in-older-adults/)
- [Nutrition and Health in Aging](https://scholariq.org/topics/nutrition-and-health-in-aging/)

## Researcher university

- [University of North Carolina at Chapel Hill](https://scholariq.org/institutions/university-of-north-carolina-at-chapel-hill/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.